Literature DB >> 10415616

Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cells.

M Cutolo1, B Villaggio, F Candido, S Valenti, M Giusti, L Felli, A Sulli, S Accardo.   

Abstract

Because some of the clinical symptoms related to rheumatoid arthritis (RA) synovitis, such as joint morning stiffness and gelling, might be related to the effects exerted by the diurnal rhythmicity of the neurohormone melatonin (MLT) on synovial immune cell activation, we decided to evaluate the influence of MLT on the production of IL-12 and nitric oxide (NO) on primary cultures of RA synovial macrophages. Synovial macrophages were also prestimulated with lipopolysaccaride (LPS). Results were compared with those obtained on cultured human myeloid monocytic cells (THP-1). A significant increase in IL-12 (p = 0.01) was found in media of MLT-stimulated synovial macrophages versus RMPI-treated synovial macrophage controls. Interestingly, a significant decrease of IL-12 (p < 0.0001) was observed in media of synovial macrophages previously activated with LPS and then treated with MLT, when compared to synovial macrophages treated with LPS alone. A significant increase in NO levels (p = 0.01) was found in MLT-stimulated synovial macrophages versus RMPI-treated synovial macrophage controls. Interestingly, a nonsignificant increase of NO levels was observed in media of synovial macrophages previously activated with LPS and then treated with MLT, when compared to cynovial macrophages treated with LPS alone. Finally, a significant increase in IL-12 (p = 0.03) and NO (p = 0.002) concentrations was observed in media of MLT-stimulated THP-1 cells versus RMPI-treated controls. Our results therefore show that MLT induces IL-12 secretion and NO production by unstimulated cultured RA synovial macrophages and human monocytic myeloid THP-1 cells. The unexpected and opposite effects on IL-12 and NO production in RA synovial macrophages treated with LPS may be related to dose-dependent mechanisms exerted by MLT or to altered cell priming in RA macrophages; these are matters of our further research. This study strongly supports the role of MLT in immune response modulation and in particular suggests a close relationship between diurnal rhythmicity of neuroendocrine pathways, cytokine and reactive oxygen intermediate production by monocyte/macrophages, and synovial arthritis symptomatology, at least in RA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415616     DOI: 10.1111/j.1749-6632.1999.tb07645.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  20 in total

Review 1.  The role of melatonin in immuno-enhancement: potential application in cancer.

Authors:  Sandra C Miller; S R Pandi-Perumal; Perumal S R Pandi; Ana I Esquifino; Daniel P Cardinali; Georges J M Maestroni
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

2.  Circadian rhythms in RA.

Authors:  M Cutolo; B Seriolo; C Craviotto; C Pizzorni; A Sulli
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

Review 3.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 4.  The melatonin-cytokine connection in rheumatoid arthritis.

Authors:  M Cutolo; G J M Maestroni
Journal:  Ann Rheum Dis       Date:  2005-08       Impact factor: 19.103

5.  Circadian fluctuations of endothelial nitric oxide synthase activity in females with rheumatoid arthritis: a pilot study.

Authors:  Kateryna Zaichko; Mykola Stanislavchuk; Nataliia Zaichko
Journal:  Rheumatol Int       Date:  2020-02-05       Impact factor: 2.631

6.  Effect of melatonin on phagocytic activity and intracellular free calcium concentration in testicular macrophages from normal and streptozotocin-induced diabetic rats.

Authors:  Joanna Pawlak; Jaipaul Singh; Robert W Lea; Krystyna Skwarlo-Sonta
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

7.  Morning melatonin serum values do not correlate with disease activity in rheumatoid arthritis: a cross-sectional study.

Authors:  Mozhgan Afkhamizadeh; Maryam Sahebari; Seyyed-Reza Seyyed-Hoseini
Journal:  Rheumatol Int       Date:  2014-02-01       Impact factor: 2.631

Review 8.  Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes.

Authors:  Rana Jahanban-Esfahlan; Saeed Mehrzadi; Russel J Reiter; Khaled Seidi; Maryam Majidinia; Hossein Bannazadeh Baghi; Nasrin Khatami; Bahman Yousefi; Alireza Sadeghpour
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

9.  Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin.

Authors:  Caroline M Forrest; Gillian M Mackay; Nicholas Stoy; Trevor W Stone; L Gail Darlington
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

Review 10.  Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment.

Authors:  Maurizio Cutolo; Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2009-04-06       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.